Harnessing immunotherapy to reverse Type 1 diabetes – FierceBiotech
FierceBiotech |
Harnessing immunotherapy to reverse Type 1 diabetes
FierceBiotech Scientists at Boston Children's Hospital have come up with a way to thwart this wayward autoimmune reaction, and it involves a protein that plays a prominent role in new immunotherapy treatments for cancer: PD-L1. PD-L1 is called an immune “checkpoint” … |
